STAT+: Trump’s FDA navigates layoffs, exits, and a new hire
This week in health care politics and policy: FDA rehires staff, former drug regulator joins Pfizer, and NIH payments cap paused.
Hello and happy Tuesday, D.C. Diagnosis readers! This week we find out whether House Republicans are willing to take the first steps towards Medicaid cuts. What are you hearing about the budget battles underway? Send news and tips to sarah.owermohle@statnews.com.
Trump administration quietly rehires FDA staff
The Trump administration has started rehiring some of the FDA employees it fired last week, the latest chapter in a haphazard and confusing layoff process, agency sources tell Lizzy Lawrence.
It’s not clear how many FDA employees were offered their jobs back, but in some cases there seemed to be broad rehirings. For example, a dozen people who worked in the office reviewing surgical and infection control devices were all reinstated. Several people working on digital health, AI-enabled technology, and other devices were also rehired.
